| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3331377
Max Phase: Preclinical
Molecular Formula: C18H18N5O7P
Molecular Weight: 447.34
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(-c4ccc5cc[nH]c5c4)ncnc32)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C18H18N5O7P/c24-15-12(6-29-31(26,27)28)30-18(16(15)25)23-8-22-14-13(20-7-21-17(14)23)10-2-1-9-3-4-19-11(9)5-10/h1-5,7-8,12,15-16,18-19,24-25H,6H2,(H2,26,27,28)/t12-,15-,16-,18-/m1/s1
Standard InChI Key: WPJAMTFEQHCMLU-HALQFCHDSA-N
Associated Targets(Human)
DNPH1 Tchem 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (25 Activities)
MCF7 (126967 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Dnph1 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (25 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 447.34 | Molecular Weight (Monoisotopic): 447.0944 | AlogP: 0.70 | #Rotatable Bonds: 5 |
| Polar Surface Area: 175.84 | Molecular Species: ACID | HBA: 9 | HBD: 5 |
| #RO5 Violations: 0 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 1.22 | CX Basic pKa: 2.91 | CX LogP: -0.93 | CX LogD: -3.38 |
| Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.27 | Np Likeness Score: 0.72 |
References
| 1. Amiable C, Paoletti J, Haouz A, Padilla A, Labesse G, Kaminski PA, Pochet S.. (2014) 6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities., 85 [PMID:25108359] [10.1016/j.ejmech.2014.07.110] |
Source
Source(1):